Upsher-Smith Laboratories

Quick facts

Marketed products

• Qudexy XR · Neurology
  Qudexy XR is an extended-release formulation of topiramate that enhances GABAergic inhibition and blocks sodium channels in the central nervous system to reduce neuronal excitability.
• Vogelxo · Other

Phase 3 pipeline

• USL255 · Cardiovascular
  USL255 is a small molecule that acts as a selective inhibitor of the sodium-activated potassium channel, Nav1.5.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Upsher-Smith Laboratories portfolio CI brief
• Upsher-Smith Laboratories pipeline updates RSS